Your Location:
Home >
Browse articles >
Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway
Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway
- Military Medical Research Vol. 9, Issue 4, Pages: 404-418(2022)
DOI: 10.1186/s40779-021-00356-x
Scan QR Code
Full Text(HTML)
Figs( 8 ) Tabs( 0 )
References
Publication Info
Metrics
16
Views
11
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Immune cells: potential carriers or agents for drug delivery to the central nervous system
The protective effects of insulin on hippocampal CA1 neurons post global ischemia
A simple and sensitive method to assess ischemia occurrence in the setting of focal cerebral ischemia in rat: A comparative study
Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies
Related Author
Shan-Shan Zhang
Ruo-Qi Li
Zhong Chen
Xiao-Ying Wang
Aaron S. Dumont
Xiang Fan
Related Institution
School of Basic Medical Sciences, Zhejiang Chinese Medical University
Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Zhejiang Chinese Medical University
Clinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine
Research Center for Neuroscience
School of Medicine

